Owner Bristol-Myers Squibb Company

Inventors Naidu, B. Narasimhulu; Connolly, Timothy P.; Patel, Manoj; Ouellet, Carl; Ueda, Yasutsugu; Sorenson, Margaret E.; Meanwell, Nicholas A.; Walker, Michael A.; Beaulieu, Francis; Weiss, Jonathan R.; Peese, Kevin M.; Chen, Li

Agent A J Park

Pub. Number AU-A-2009225577

PCT Pub. Number WO2009/117540

Priority 12/406,268 18.03.09 US; 61/037,729 19.03.08 US

Filing date 19 March 2009

Wipo publication date 24 September 2009

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61K 31/5386 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/18 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 493/18 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system